Pilot implementation of a home-care programme with chlamydia, gonorrhoea, hepatitis B, and syphilis self-sampling in HIV-positive men who have sex with men

J. Leenen; C. J. P. A. Hoebe; R. P. Ackens; D. Posthouwer; I. H. M. van Loo; P. F. G. Wolffs; N. H. T. M. Dukers-Muijrers

doi:10.1186/s12879-020-05658-4

Pilot implementation of a home-care programme with chlamydia, gonorrhoea, hepatitis B, and syphilis self-sampling in HIV-positive men who have sex with men

J. Leenen, C. J. P. A. Hoebe, R. P. Ackens, D. Posthouwer, I. H. M. van Loo, P. F. G. Wolffs, N. H. T. M. Dukers-Muijrers^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

BackgroundNot all men who have sex with men (MSM) at risk for sexually transmitted infections (STIs) and human immunodeficiency virus (HIV) infection currently receive sexual healthcare. To increase the coverage of high-quality HIV/STI care for MSM, we developed a home-care programme, as extended STI clinic care. This programme included home sampling for testing, combined with treatment and sexual health counselling. Here, we pilot implemented the programme in a hospital setting (HIV-positive MSM) to determine the factors for the successful implementation of STI home sampling strategies.MethodsHealthcare providers from the HIV hospital treatment centre (Maastricht) were invited to offer free STI sampling kits (syphilis, hepatitis B, [extra]genital chlamydia and gonorrhoea laboratory testing) to their HIV-positive MSM patients (March to May 2018). To evaluate implementation of the program, quantitative and qualitative data were collected to assess adoption (HIV care providers offered sampling kits to MSM), participation (MSM accepted the sampling kits) and sampling-kit return, STI diagnoses, and implementation experiences.ResultsAdoption was 85.3% (110/129), participation was 58.2% (64/110), and sampling-kit return was 43.8% (28/64). Of the tested MSM, 64.3% (18/28) did not recently (

Original language	English
Article number	925
Number of pages	9
Journal	BMC Infectious Diseases
Volume	20
Issue number	1
DOIs	https://doi.org/10.1186/s12879-020-05658-4
Publication status	Published - 4 Dec 2020

Keywords

Home sampling
STI
MSM
HIV care
Implementation
SEXUALLY-TRANSMITTED INFECTIONS
NEISSERIA-GONORRHOEAE
PREVENTION
TRACHOMATIS
BARRIERS
CENTERS
GAY

Access to Document

10.1186/s12879-020-05658-4Licence: CC BY

Cite this

Leenen, J., Hoebe, C. J. P. A., Ackens, R. P., Posthouwer, D., van Loo, I. H. M., Wolffs, P. F. G., & Dukers-Muijrers, N. H. T. M. (2020). Pilot implementation of a home-care programme with chlamydia, gonorrhoea, hepatitis B, and syphilis self-sampling in HIV-positive men who have sex with men. BMC Infectious Diseases, 20(1), Article 925. https://doi.org/10.1186/s12879-020-05658-4

@article{2eda5b66db6e4815bde6faf7ff7ed296,

title = "Pilot implementation of a home-care programme with chlamydia, gonorrhoea, hepatitis B, and syphilis self-sampling in HIV-positive men who have sex with men",

abstract = "BackgroundNot all men who have sex with men (MSM) at risk for sexually transmitted infections (STIs) and human immunodeficiency virus (HIV) infection currently receive sexual healthcare. To increase the coverage of high-quality HIV/STI care for MSM, we developed a home-care programme, as extended STI clinic care. This programme included home sampling for testing, combined with treatment and sexual health counselling. Here, we pilot implemented the programme in a hospital setting (HIV-positive MSM) to determine the factors for the successful implementation of STI home sampling strategies.MethodsHealthcare providers from the HIV hospital treatment centre (Maastricht) were invited to offer free STI sampling kits (syphilis, hepatitis B, [extra]genital chlamydia and gonorrhoea laboratory testing) to their HIV-positive MSM patients (March to May 2018). To evaluate implementation of the program, quantitative and qualitative data were collected to assess adoption (HIV care providers offered sampling kits to MSM), participation (MSM accepted the sampling kits) and sampling-kit return, STI diagnoses, and implementation experiences.ResultsAdoption was 85.3% (110/129), participation was 58.2% (64/110), and sampling-kit return was 43.8% (28/64). Of the tested MSM, 64.3% (18/28) did not recently (",

keywords = "Home sampling, STI, MSM, HIV care, Implementation, SEXUALLY-TRANSMITTED INFECTIONS, NEISSERIA-GONORRHOEAE, PREVENTION, TRACHOMATIS, BARRIERS, CENTERS, GAY",

author = "J. Leenen and Hoebe, {C. J. P. A.} and Ackens, {R. P.} and D. Posthouwer and {van Loo}, {I. H. M.} and Wolffs, {P. F. G.} and Dukers-Muijrers, {N. H. T. M.}",

note = "Publisher Copyright: {\textcopyright} 2020, The Author(s).",

year = "2020",

month = dec,

day = "4",

doi = "10.1186/s12879-020-05658-4",

language = "English",

volume = "20",

journal = "BMC Infectious Diseases",

issn = "1471-2334",

publisher = "BioMed Central Ltd",

number = "1",

}

TY - JOUR

T1 - Pilot implementation of a home-care programme with chlamydia, gonorrhoea, hepatitis B, and syphilis self-sampling in HIV-positive men who have sex with men

AU - Leenen, J.

AU - Hoebe, C. J. P. A.

AU - Ackens, R. P.

AU - Posthouwer, D.

AU - van Loo, I. H. M.

AU - Wolffs, P. F. G.

AU - Dukers-Muijrers, N. H. T. M.

PY - 2020/12/4

Y1 - 2020/12/4

N2 - BackgroundNot all men who have sex with men (MSM) at risk for sexually transmitted infections (STIs) and human immunodeficiency virus (HIV) infection currently receive sexual healthcare. To increase the coverage of high-quality HIV/STI care for MSM, we developed a home-care programme, as extended STI clinic care. This programme included home sampling for testing, combined with treatment and sexual health counselling. Here, we pilot implemented the programme in a hospital setting (HIV-positive MSM) to determine the factors for the successful implementation of STI home sampling strategies.MethodsHealthcare providers from the HIV hospital treatment centre (Maastricht) were invited to offer free STI sampling kits (syphilis, hepatitis B, [extra]genital chlamydia and gonorrhoea laboratory testing) to their HIV-positive MSM patients (March to May 2018). To evaluate implementation of the program, quantitative and qualitative data were collected to assess adoption (HIV care providers offered sampling kits to MSM), participation (MSM accepted the sampling kits) and sampling-kit return, STI diagnoses, and implementation experiences.ResultsAdoption was 85.3% (110/129), participation was 58.2% (64/110), and sampling-kit return was 43.8% (28/64). Of the tested MSM, 64.3% (18/28) did not recently (

AB - BackgroundNot all men who have sex with men (MSM) at risk for sexually transmitted infections (STIs) and human immunodeficiency virus (HIV) infection currently receive sexual healthcare. To increase the coverage of high-quality HIV/STI care for MSM, we developed a home-care programme, as extended STI clinic care. This programme included home sampling for testing, combined with treatment and sexual health counselling. Here, we pilot implemented the programme in a hospital setting (HIV-positive MSM) to determine the factors for the successful implementation of STI home sampling strategies.MethodsHealthcare providers from the HIV hospital treatment centre (Maastricht) were invited to offer free STI sampling kits (syphilis, hepatitis B, [extra]genital chlamydia and gonorrhoea laboratory testing) to their HIV-positive MSM patients (March to May 2018). To evaluate implementation of the program, quantitative and qualitative data were collected to assess adoption (HIV care providers offered sampling kits to MSM), participation (MSM accepted the sampling kits) and sampling-kit return, STI diagnoses, and implementation experiences.ResultsAdoption was 85.3% (110/129), participation was 58.2% (64/110), and sampling-kit return was 43.8% (28/64). Of the tested MSM, 64.3% (18/28) did not recently (

KW - Home sampling

KW - STI

KW - MSM

KW - HIV care

KW - Implementation

KW - SEXUALLY-TRANSMITTED INFECTIONS

KW - NEISSERIA-GONORRHOEAE

KW - PREVENTION

KW - TRACHOMATIS

KW - BARRIERS

KW - CENTERS

KW - GAY

U2 - 10.1186/s12879-020-05658-4

DO - 10.1186/s12879-020-05658-4

M3 - Article

C2 - 33276727

SN - 1471-2334

VL - 20

JO - BMC Infectious Diseases

JF - BMC Infectious Diseases

IS - 1

M1 - 925

ER -